Drug Type Small molecule drug |
Synonyms Compound 21 |
Target |
Mechanism β-lactamase inhibitors(Beta Lactamase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H23FN2O5S |
InChIKeyUSWNHACQHYTNKS-RGOPNGEDSA-N |
CAS Registry3031470-31-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Urethral Infection | Preclinical | JP | 01 Oct 2021 |